Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness.
about
Risk Factors of HIV and Other Sexually Transmitted Infections in China: A Systematic Review of ReviewsChanges in HIV incidence among people who inject drugs in Taiwan following introduction of a harm reduction program: a study of two cohortsNational income inequality and declining GDP growth rates are associated with increases in HIV diagnoses among people who inject drugs in Europe: a panel data analysisOverview of HIV molecular epidemiology among people who inject drugs in Europe and Asia.Public health and international drug policy.Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study.Prevention, early intervention, and harm reduction of substance use in adolescents.Needle exchange programs for the prevention of hepatitis C virus infection in people who inject drugs: a systematic review with meta-analysis.A Systematic Review and Meta-analysis of Psychosocial Interventions to Reduce Drug and Sexual Blood Borne Virus Risk Behaviours Among People Who Inject DrugsRapid decline in HCV incidence among people who inject drugs associated with national scale-up in coverage of a combination of harm reduction interventions.Attitudes Toward Addiction, Methadone Treatment, and Recovery Among HIV-Infected Ukrainian Prisoners Who Inject Drugs: Incarceration Effects and Exploration of Mediators.Tailored combination prevention packages and PrEP for young key populations.Disinfection of syringes contaminated with hepatitis C virus by rinsing with household products.Survival of Hepatitis C Virus in Syringes Is Dependent on the Design of the Syringe-Needle and Dead Space Volume.Commentary on Nolan et al. (2014): Opiate substitution treatment and hepatitis C virus prevention: building an evidence base?A needle in the haystack--the dire straits of needle exchange in Hungary.Can HIV and Hepatitis C Virus Infection be Eliminated Among Persons Who Inject Drugs?Individual-level needle and syringe coverage in Melbourne, Australia: a longitudinal, descriptive analysis.Effectiveness of needle and syringe Programmes in people who inject drugs - An overview of systematic reviewsDrug preparation, injection, and sharing practices in Tajikistan: a qualitative study in Kulob and KhorogA cross-national analysis of the effects of methadone maintenance and needle and syringe program implementation on incidence rates of HIV in Europe from 1995 to 2011.In Their Own Voices: Breaking the Vicious Cycle of Addiction, Treatment and Criminal Justice Among People who Inject Drugs in Ukraine.Harm reduction for young people who use prescription opioids extra-medically: Obstacles and opportunities.Alternate Routes of Administration among Prescription Opioid Misusers and Associations with Sexual HIV Transmission Risk BehaviorsReducing HIV infection in people who inject drugs is impossible without targeting recently-infected subjects.Modeling a dynamic bi-layer contact network of injection drug users and the spread of blood-borne infections.The acceptability and feasibility of a brief psychosocial intervention to reduce blood-borne virus risk behaviours among people who inject drugs: a randomised control feasibility trial of a psychosocial intervention (the PROTECT study) versus treatmInfluence of different drugs on HIV risk in people who inject: systematic review and meta-analysis.Novel interventions to prevent HIV and HCV among persons who inject drugs.Risk behaviour determinants among people who inject drugs in Stockholm, Sweden over a 10-year period, from 2002 to 2012.Review article: treatment as prevention - targeting people who inject drugs as a pathway towards hepatitis C eradication.Programmatic Implications of Acute and Early HIV Infection.Direct-acting antiviral agents for HCV infection affecting people who inject drugs.Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs.Barriers to Access to Sterile Syringes as Perceived by Pharmacists and Injecting Drug Users: Implications for Harm Reduction in Lebanon.Higher incidence of HCV in females compared to males who inject drugs: A systematic review and meta-analysis.Is the recent emergence of mephedrone injecting in the United Kingdom associated with elevated risk behaviours and blood borne virus infection?Syringe Stockpiling by Persons Who Inject Drugs: An Evaluation of Current Measures for Needle and Syringe Program Coverage.Social-demographic shift in drug users at the first-ever- methadone maintenance treatment in Wuhan, China.Needle syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis.
P2860
Q26782790-66EF572D-5C4A-4E42-9E55-EEF24BEBA5E7Q28542085-D7A49A31-4E3A-4231-91F7-438D69F99931Q28546434-517F8996-3BD7-4BC8-A723-94DDFA3FE6BBQ30249677-CD8FD554-73F5-4457-BEB8-7F43744CE780Q30377895-C100251F-1B44-4FBC-9326-2DBCB6A0196DQ33592665-FF8F7961-972B-440D-AC4A-91219D72CE0DQ33641576-0AF2C4FA-E41F-4D78-AB09-4EB9006E88A2Q33702754-9431AD67-BD5F-44EA-B298-7FEB50D57A20Q33854811-3E2AA797-5FEA-4B3F-9F7F-3FFD9E041A21Q34028058-63116AAD-B1BC-4155-A140-45CCBE8567B4Q34676524-E0D0A580-6E6F-482D-934F-0173782B772AQ35131207-C02DBD89-631D-4269-BFF6-F4A798B31FF4Q35628270-06333EDE-AF73-4562-AC54-35DA7D7B9985Q35832272-1558B395-F781-40BA-962C-F5409897CEFFQ35903698-BFD8D784-3877-403C-A650-1E041C719B6FQ35924703-E7895B93-3EB6-4D05-A842-92E21F680707Q35998417-EFA6D2D1-2B24-4612-B93D-FC603D6A575BQ36108046-DF19B296-8107-481F-9AED-D1288B7F1706Q36343824-2D4C9B0C-BEB5-401C-82E5-313D1B55228EQ36960123-4304DB72-4EFE-4A16-B750-28DF464807DFQ36984579-51B6769D-45C7-45E0-AAC1-AB73875DFE71Q37117229-4FC25B67-F25A-43BD-9CF5-12CBF55DC9F8Q37154709-E8E29688-811C-4105-9238-702E43B2B855Q37184992-7DF91C5C-FEF7-4DDD-9BF4-FC3C6CCD77F1Q37409652-60799196-D118-4D0B-83E0-7DEFE2505456Q37499070-E88E6576-A99C-4EA9-9CD0-E8E3AB51B54BQ37713321-F7657722-C683-4380-ADB6-6D85A27F2C5CQ38315761-4E42FE03-A019-471D-A0A8-B4359003EEE4Q38318678-19AFC1CF-42AD-480A-80E1-4386749D65D4Q38372109-7ECF2C2E-70FA-4E12-A8D6-7EA0837A7AC8Q38380343-18F33B15-DD68-4202-9CBC-443B53C5A980Q38574468-D1D39929-CA4A-40C8-8D1A-5AFFAA0DD140Q38613271-84DDCD2D-995B-4987-966D-3955A7F91A92Q38661825-5B8C6E71-ECD0-4F59-AA2E-1231BF09698FQ38827011-981A428C-849D-4CE2-A68C-0CCA711B852DQ38993437-80212E27-E5F0-4CEE-967C-789E829985E6Q39754020-CE2053D0-FF4C-4A0A-A75B-5246B84CB954Q39860271-DDB80A3C-E159-4004-9B2B-8FC81B9097AAQ40042274-1864D791-491F-438D-8D6B-002F0CB9E403Q40048259-ABC3A23E-3C39-49CF-83EF-16E8CB785612
P2860
Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Interventions to prevent HIV a ...... ess evidence of effectiveness.
@ast
Interventions to prevent HIV a ...... ess evidence of effectiveness.
@en
Interventions to prevent HIV a ...... ess evidence of effectiveness.
@nl
type
label
Interventions to prevent HIV a ...... ess evidence of effectiveness.
@ast
Interventions to prevent HIV a ...... ess evidence of effectiveness.
@en
Interventions to prevent HIV a ...... ess evidence of effectiveness.
@nl
prefLabel
Interventions to prevent HIV a ...... ess evidence of effectiveness.
@ast
Interventions to prevent HIV a ...... ess evidence of effectiveness.
@en
Interventions to prevent HIV a ...... ess evidence of effectiveness.
@nl
P2093
P50
P1476
Interventions to prevent HIV a ...... ess evidence of effectiveness.
@en
P2093
Anastasia Pharris
Avril Taylor
David Goldberg
Esther Aspinall
Eva van Velzen
Georgina J MacArthur
Kirsty Roy
Mika Salminen
Sharon J Hutchinson
P356
10.1016/J.DRUGPO.2013.07.001
P407
P577
2013-08-21T00:00:00Z